Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Healthcare Realty Trust Incorporated (HR) has a Wall Street consensus price target of $19.67, based on estimates from 29 covering analysts. With the stock currently trading at $18.45, this represents a potential upside of +6.6%. The company has a market capitalization of $6.49B.
Analyst price targets range from a low of $19.00 to a high of $21.00, representing a 10% spread in expectations. The median target of $19.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 7 analysts rating the stock as a Buy or Strong Buy,20 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, HR trades at a trailing P/E of -26.0x. Analysts expect EPS to grow +90.0% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how HR stacks up against sector leader Welltower Inc..
Start ComparisonThe consensus price target for HR is $19.67, close to the current price of $18.45 (6.6% implied move). Based on 29 analyst estimates, the stock appears fairly valued near current levels.
HR has a consensus rating of "Hold" based on 29 Wall Street analysts. The rating breakdown is mixed, with 20 Hold ratings making up the largest segment. The consensus 12-month price target of $19.67 implies 6.6% upside from current levels.
HR's current price is $18.45 with a consensus target of $19.67 (6.6% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $21 for HR, while the most conservative target is $19. The consensus of $19.67 represents the median expectation. These targets typically reflect 12-month expectations.
HR is heavily covered by Wall Street, with 29 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 20 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HR stock forecast based on 29 Wall Street analysts shows a consensus price target of $19.67, with estimates ranging from $19 (bear case) to $21 (bull case). The median consensus rating is "Hold".
HR appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $19.67 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HR analyst price targets range from $19 to $21, a 10% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $19.67 consensus represents the middle ground.